February 28, 2001 |
Drug maker Alza Corp. on Tuesday projected at least 20% growth in its revenue and earnings per share this year amid continued strong sales of its own drugs as well as products such as the NicoDerm smoking-control patch that use its patented drug delivery technologies. Last year, Alza's revenue rose 24% and earnings per share, after one-time items, grew 28% from a year earlier to 82 cents a share.
March 27, 2001 |
Drug giant Johnson & Johnson may buy Alza Corp. for about $10 billion in stock to gain an attention-deficit disorder treatment and timed-release medicines, people familiar with the companies' discussions said Monday. Alza stockholders would exchange each of their shares for about a half-share of Johnson & Johnson, sources said. The deal talks, first reported in the Wall Street Journal and the Financial Times on Monday, sent Alza's shares soaring $8.70, or 29%, to close at $38.
June 22, 1999 |
Pharmaceutical giant Abbott Laboratories announced Monday that it will acquire Alza Corp., a Palo Alto company that has developed novel drug delivery products, including the NicoDerm skin patch for smokers who want to quit. The $7.3-billion deal is one of several recently in which large drug companies have gobbled up smaller ones--particularly biotechnology firms--in an effort to expand their growth potential. In this case, Abbott Park, Ill.
April 28, 1992 |
A big change is brewing in the ranks of California's fastest-growing companies. The Times Growth 100 list has always been dominated by high-tech enterprises, and 1991 was no exception: About half the companies are in some way part of the computer industry. But a changing of the guard is underway. Computer manufacturers and chip-making companies are suddenly sliding down the Growth 100 list, and software companies are finding their way to the top.
April 27, 1993
Companies listed alphabetically with their rankings on The Times 100, Sales 100, Market Value 100, Growth 100 and Employer 100 lists. Mrkt Times Sales Value Grwth Emply Company 100 100 100 100 100 20th Century Industries 31 79 50 3Com Corp. 71 41 ADAC Laboratories 47 84 ALZA Corp. 33 16 AST Research Inc. 36 72 38 93 Acuson Corp. 48 Adaptec Inc. 50 96 5 Adia Services Inc. 89 Adobe Systems Inc. 16 74 Advanced Marketing 77 Advanced Micro Devices 24 57 39 76 51 Allergan Inc.
May 3, 1988 |
The last thing Alza Corp. ever wanted was a monopoly. When G. D. Searle & Co. withdrew its intrauterine device from the market in January, 1986, Alza became, by default, the last drug company in America to sell an IUD.
May 6, 1997
Companies ranked by market value, which is stock price times the number of shares outstanding. Also shown: book value, which is a company's theoretical liquidation value, and the market-to-book ratio for each company. *--* 4/18/97 Book Market- '95 market value Value to-book Rank Rank Company (millions) (millions) ratio 1 1 Intel Corp. $112,100 $16,872 6.64% 2 3 Walt Disney Co. 51,817 16,086 3.22 3 2 Hewlett-Packard Co. 50,682 13,438 3.77 4 4 Chevron Corp. 42,223 15,623 2.7 5 BankAmerica Corp.